Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer

Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer

10.1111/1759-7714.14667

Saved in:

Bibliographic Details
Main Authors:	Huang, Yiqing, Zhao, Joseph J, Soon, Yu Yang, Wong, Alvin, Aminkeng, Folefac, Ang, Yvonne, Asokumaran, Yugarajah, Low, Jia Li, Lee, Matilda, Choo, Joan RE, Chan, Gloria, Kee, Adrian, Tay, Sen Hee, Goh, Boon Cher, Soo, Ross A
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	WILEY 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Respiratory System consolidation Durvalumab non-small cell lung cancer real-world stage III TO-LYMPHOCYTE RATIO EGFR MUTATION CLINICAL-OUTCOMES SUBGROUP ANALYSIS NSCLC ONCOLOGY CHEMORADIATION RADIOTHERAPY HALLMARKS PATTERNS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235035
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach
by: Salto-Tellez, M., et al.
Published: (2014)

Brief Report: Droplet Digital Polymerase Chain Reaction Versus Plasma Next-Generation Sequencing in Detecting Clearance of Plasma EGFR Mutations and Carcinoembryonic Antigen Levels as a Surrogate Measure
by: Saw, Stephanie PL, et al.
Published: (2024)

Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma
by: Leong, C.N., et al.
Published: (2016)

REGULATION OF AMPK ACTIVATION AND ITS ROLE IN CELL DEATH INDUCED BY GLUCOSE STARVATION IN LKB1-MUTANT HUMAN LUNG CANCER CELLS
by: REN YI
Published: (2019)

First-line afatinib for the treatment of EGFR mutation-positive non-small-cell lung cancer in the 'real-world' clinical setting
by: Park, Keunchil, et al.
Published: (2022)

Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
by: Chang, Gee-Chen, et al.
Published: (2022)

TARGETING THE PIK3 PATHWAY IN NON-SMALL CELL LUNG CANCER
by: DANIEL TAN SHAO WENG
Published: (2017)

Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors
by: Chin, T.-M., et al.
Published: (2021)

Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients
by: Huang, Yiqing, et al.
Published: (2022)

Applying the ASCO and ESMO Value Frameworks to nasopharyngeal cancer treatments: Is adding induction chemotherapy or adjuvant chemotherapy to concurrent chemoradiotherapy worthwhile?
by: Tan, Teng Hwee, et al.
Published: (2023)

Blocking aerobic glycolysis by targeting pyruvate dehydrogenase kinase in combination with egfr tki and ionizing radiation increases therapeutic effect in non-small cell lung cancer cells
by: Dyrstad, Sissel E., et al.
Published: (2022)

A comparative study of suction-induced seepage consolidation versus centrifuge consolidation
by: Robinson, R.G., et al.
Published: (2014)

Applying the ASCO and European Society for Medical Oncology Value Frameworks to Nasopharyngeal Cancer Treatments: Is Adding Induction Chemotherapy or Adjuvant Chemotherapy to Concurrent Chemoradiotherapy Worthwhile?
by: Tan, Teng Hwee, et al.
Published: (2022)

A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)
by: Ngoi, Natalie YL, et al.
Published: (2020)

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy
by: Limviphuvadh, Vachiranee, et al.
Published: (2018)

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: Interim results from 2 prospective phase 2 clinical trials
by: Kong, L., et al.
Published: (2016)

Cucurbitacin B causes increased radiation sensitivity of human breast cancer cells via G2/M cell cycle arrest
by: Duangmano,S., et al.
Published: (2015)

Intracellular acidosis promotes mitochondrial apoptosis pathway: Role of EMMPRIN down-regulation via specific single-chain fv intrabody
by: Thammasit,P., et al.
Published: (2015)

Erratum: cucurbitacin B causes increased radiation sensitivity of human breast cancer cells via G2/M cell cycle arrest (Journal of Oncology (2015))
by: Duangmano,S., et al.
Published: (2015)

Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective
by: Thongprasert,S., et al.
Published: (2015)

Capecitabine and weekly paclitaxel as first-line therapy in Thai patients with metastatic breast cancer
by: Chitapanarux,I., et al.
Published: (2015)

New observational method for prediction of one-dimensional consolidation settlement
by: Guo, Wei, et al.
Published: (2017)

Protocol for a scoping review of digital health for older adults with cancer and their families
by: Cheng, K.K.-F., et al.
Published: (2021)

Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR plus non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance
by: Ma, Jun, et al.
Published: (2024)

Dilemmas of democratic consolidation in Indonesia
by: Davidson, J.S.
Published: (2011)

Adjuvant High-Dose Rate Brachytherapy after Chemoradiation for Treatment of Early T-Stage Nasopharyngeal Carcinoma
by: Lu, J.J., et al.
Published: (2012)

Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?
by: Lee, Matilda X, et al.
Published: (2021)

Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma (NPC).
by: Walsh, Robert John, et al.
Published: (2023)

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
by: Tan, Wan-Ling, et al.
Published: (2022)

Ellagic acid, a component of pomegranate fruit juice, suppresses androgen-dependent prostate carcinogenesis via induction of apoptosis
by: Naiki-Ito,A., et al.
Published: (2015)

Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus
by: Cheng,A., et al.
Published: (2015)

Hubungan Polimorfisme Gen CYP2C19 dengan Reaktivitas Trombosit pada Pasien Angina Pektoris Stabil dalam Terapi Klopidogrel di Rumah Sakit Umum Dr. Saiful Anwar Malang
by: RENI P., ARINDHA
Published: (2016)

Arrowroot (Maranta arundinacea L.) as a new potential functional food: A scoping review
by: Fidianingsih, I., et al.
Published: (2022)

Hemi-mandibulectomy without bony reconstruction: A case report of mandibular metastasis from a silent differentiated papillary thyroid cancer
by: Wahyono, Artanto, et al.
Published: (2022)

Sleep disorder among patients with breast cancer: A concept analysis
by: Aini, Nur, et al.
Published: (2022)

Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
by: Ratnasari, Neneng, et al.
Published: (2022)

Classification of adeno carcinoma, high squamous intraephithelial lesion, and squamous cell carcinoma in Pap smear images based on extreme learning machine
by: Suksmono, A.B., et al.
Published: (2021)

Consolidation characteristics of lumpy fill
by: YANG JUNWEI
Published: (2010)

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial
by: Schuler, M, et al.
Published: (2024)

The signature of Γ+ 0(n)
by: Lang, M.-L.
Published: (2014)